Cardiac amyloidosis (CA) is an infiltrative restrictive cardiomyopathy caused by the
deposition of amyloid fibrils in the myocardium. It manifests in two primary subtypes …

Nanoparticles hold a great potential for therapeutic targeting due to their ability to improve
the stability of encapsulated cargo and promote the transport of cargo across membranes to …

Purpose The diagnosis of amyloidosis is important for early intervention, disease monitoring,
and prevention of complications and progression. Carpal tunnel syndrome (CTS) and trigger …

Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma that is
characterized by the overproduction of an IgM monoclonal protein. It may cause …

Cardiac amyloidosis (CA) represents a myocardial disorder developed by fibril deposition of
a heterogeneous group of misfolding proteins. Despite being rare, a high clinical index of …

BACKGROUND Amyloidosis is a rare disease characterized by extracellular deposition of
misfolded protein aggregated into insoluble fibrils. Gastrointestinal involvement in systemic …

Purpose: Systemic amyloidosis is a group of rare, life-threatening disorders characterized by
the deposition of amyloid plaques in numerous tissues. Vitreous involvement can occur in …

BEERSE, BELGIUM, 21 May, 2021-The Janssen Pharmaceutical Companies of Johnson &
Johnson today announced that the Committee for Medicinal Products for Human Use …

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines …

Le amiloidosi sono un gruppo eterogeneo di malattie caratterizzate dalla deposizione di
proteine ripiegate in modo anomalo nei tessuti. Il termine amiloidosi è principalmente …